Synapse Biomedical Inc. (SBI) was founded in September 2002 in Oberlin, Ohio. Synapse Biomedical is focused on the commercialization of the NeuRx® DPS, a life-transforming neurostimulation platform technology, to treat people with respiratory insufficiency. The NeuRx® DPS was developed over the course of 20 years through a joint effort of physicians and engineers at several institutions, including Case Western Reserve University, University Hospitals Case Medical Center and the Veterans Administration Medical Center.
The NeuRx DPS® was developed at Case Western Reserve University and the University Hospitals Case Medical Center. Funding was made possible in part by the Department of Veterans Affairs, who contributed more than $1 million.
Synapse’s Co-founder, CEO and President is Anthony Ignagni. The Chief Operating Officer & Managing Director Europe is Moustapha Diop.